HALOZYME THERAPEUTICS INC (HALO)

US40637H1095 - Common Stock

49  +3.3 (+7.22%)

After market: 49.51 +0.51 (+1.04%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
443.3M
65.66%		660.1M
48.91%		829.253M
25.63%		1.023B
23.36%
EBITDA
YoY % growth
278.9M
88.96%		339M
21.55%		424.93M
25.35%		571.73M
34.55%
EBIT
YoY % growth
275.9M
91.20%		289.4M
4.89%		340.074M
17.51%		538.11M
58.23%
Operating Margin
62.24%43.84%41.01%52.60%
EPS
YoY % growth
1.92
113.33%		2.22
15.62%		2.78
25.23%		4.24
52.39%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		1.20
46.16%
Revenue
Q2Q % growth		296.75M
29.00%
EBITDA
Q2Q % growth		192.43M
3.52%
EBIT
Q2Q % growth		165.57M
63.87%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 1.27
69.33%		1.000.2726.79%
Q2 2024
Q2Q % growth		 0.91
22.97%		0.770.1417.68%
Q1 2024
Q2Q % growth		 0.79
68.09%		0.710.0811.44%
Q4 2023
Q2Q % growth		 0.82
70.83%		0.84-0.02-2.55%
Q3 2023
Q2Q % growth
Q2 2023
Q2Q % growth
Q1 2023
Q2Q % growth
Q4 2022
Q2Q % growth
Q3 2022
Q2Q % growth
Q2 2022
Q2Q % growth
Q1 2022
Q2Q % growth
Q4 2021
Q2Q % growth
Q3 2021
Q2Q % growth
Q2 2021
Q2Q % growth
Q1 2021
Q2Q % growth
Q4 2020
Q2Q % growth
Q3 2020
Q2Q % growth
Q2 2020
Q2Q % growth
Q1 2020
Q2Q % growth
Q4 2019
Q2Q % growth
Q3 2019
Q2Q % growth
Q2 2019
Q2Q % growth
Q1 2019
Q2Q % growth
Q4 2018
Q2Q % growth
Q3 2018
Q2Q % growth
Q2 2018
Q2Q % growth
Q1 2018
Q2Q % growth
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 290.084M
34.28%		256.08M34.004M13.28%
Q2 2024
Q2Q % growth		 231.353M
4.67%		209.04M22.313M10.67%
Q1 2024
Q2Q % growth		 195.879M
20.81%		203.77M-7.891M-3.87%
Q4 2023
Q2Q % growth		 230.039M
26.74%		235.76M-5.721M-2.43%
Q3 2023
Q2Q % growth
Q2 2023
Q2Q % growth
Q1 2023
Q2Q % growth
Q4 2022
Q2Q % growth
Q3 2022
Q2Q % growth
Q2 2022
Q2Q % growth
Q1 2022
Q2Q % growth
Q4 2021
Q2Q % growth
Q3 2021
Q2Q % growth
Q2 2021
Q2Q % growth
Q1 2021
Q2Q % growth
Q4 2020
Q2Q % growth
Q3 2020
Q2Q % growth
Q2 2020
Q2Q % growth
Q1 2020
Q2Q % growth
Q4 2019
Q2Q % growth
Q3 2019
Q2Q % growth
Q2 2019
Q2Q % growth
Q1 2019
Q2Q % growth
Q4 2018
Q2Q % growth
Q3 2018
Q2Q % growth
Q2 2018
Q2Q % growth
Q1 2018
Q2Q % growth
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-3.29% -3.29% 4.81% 4.19%
Revenue2.3% 2.3% 1.99% 1.29%